Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The evolving landscape of prostate cancer somatic mutations. | Prostate | 2022 | 35657155 | PubTator, text mining | PubMed |
| Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion. | J Cancer Res Clin Oncol | 2022 | 35648195 | PubTator, text mining | PubMed |
| Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs. | Noncoding RNA | 2022 | 35645336 | PubTator, text mining | PubMed |
| A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. | Int J Genomics | 2022 | 35634481 | PubTator, text mining | PubMed |
| Correlation of NTRK1 Downregulation with Low Levels of Tumor-Infiltrating Immune Cells and Poor Prognosis of Prostate Cancer Revealed by Gene Network Analysis. | Genes (Basel) | 2022 | 35627227 | PubTator, text mining | PubMed |
| Fusion Genes in Prostate Cancer: A Comparison in Men of African and European Descent. | Biology (Basel) | 2022 | 35625354 | PubTator, text mining | PubMed |
| Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing. | Br J Cancer | 2022 | 35606463 | PubTator, text mining | PubMed |
| CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease. | Clin Cancer Res | 2022 | 35604681 | PubTator, text mining | PubMed |
| The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer. | J Exp Clin Cancer Res | 2022 | 35590370 | PubTator, text mining | PubMed |
| Plant-Based Natural Bioactive Compounds 2,4-Ditert-Butylphenolas: A Potential Candidates Against SARS-Cov-2019. | Energy Nexus | 2022 | 35578668 | PubTator, text mining | PubMed |
| In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis. | Mol Oncol | 2022 | 35574900 | PubTator, text mining | PubMed |
| A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma. | Ann Transl Med | 2022 | 35571443 | PubTator, text mining | PubMed |
| BCOR-CCNB3 sarcoma with concurrent RNF213-SLC26A11 gene fusion: a rare sarcoma with altered histopathological features after chemotherapy. | World J Surg Oncol | 2022 | 35568949 | PubTator, text mining | PubMed |
| Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer. | Oncogene | 2022 | 35568739 | PubTator, text mining | PubMed |
| Malignant Superficial Mesenchymal Tumors in Children. | Cancers (Basel) | 2022 | 35565289 | PubTator, text mining | PubMed |
| Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma. | Cancers (Basel) | 2022 | 35565286 | PubTator, text mining | PubMed |
| The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer. | Int J Mol Sci | 2022 | 35563163 | PubTator, text mining | PubMed |
| Induction of the BRAFV600E Mutation in Thyroid Cells Leads to Frequent Hypermethylation. | Clin Exp Otorhinolaryngol | 2022 | 35538718 | PubTator, text mining | PubMed |
| Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report. | Front Oncol | 2022 | 35530342 | PubTator, text mining | PubMed |
| Ewing Sarcoma and Primitive Neuroectodermal Tumor of the Thoracic Esophagus: Case Report and Comprehensive Literature Review. | Case Rep Oncol | 2022 | 35529299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=23